Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Concentrations of High-dose Amoxicillin (MAX-AMOX)
NCT04070469Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin in bacterial infection, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Dec 2019; status: completed.
02
Drugs
amoxicillin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04070469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04070469.